Cargando…
Rethinking treatment paradigms for the deployment of SARS-CoV-2 antiviral drugs on the shifting landscape of new variants
Autores principales: | Hentzien, Maxime, Owen, Andrew, Strub-Wourgaft, Nathalie, Pérez-Casas, Carmen, Trøseid, Marius, Calmy, Alexandra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9597299/ https://www.ncbi.nlm.nih.gov/pubmed/36312942 http://dx.doi.org/10.3389/fmicb.2022.998287 |
Ejemplares similares
-
A monoclonal antibody stands out against omicron subvariants: a call to action for a wider access to bebtelovimab
por: Hentzien, Maxime, et al.
Publicado: (2022) -
Rethinking the Antibiotic Discovery Paradigm
por: Hancock, Robert E.W.
Publicado: (2015) -
Rethinking the Current “Stage-and-Wait” Paradigm
por: Ragoler, Morel, et al.
Publicado: (2023) -
Can a single dose of Modified Vaccinia Ankara-Bavarian Nordic vaccine protect against mpox?
por: Ogoina, Dimie, et al.
Publicado: (2023) -
Unique Genomic Landscape of High-Grade Neuroendocrine Cervical Carcinoma: Implications for Rethinking Current Treatment Paradigms
por: Eskander, Ramez N., et al.
Publicado: (2020)